Freddo James L 4
4 · ANADYS PHARMACEUTICALS INC · Filed Aug 20, 2009
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2009-08-18+35,000→ 35,000 totalExercise: $2.24From: 2010-02-18Exp: 2019-08-17→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable six months from the date of grant with the remaining shares subject to the option vesting in equal monthly installments evenly over the next 18 months such that all shares subject to the option will be fully vested and exercisable as of August 18, 2011.